Identification of Genetic Factors that Modify Clinical Onset of Huntington’s DiseaseJong‐Min Lee, Richard H. Myers, Lesley Jones et al.|Cell|2015Cited by 671
Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic BoundariesMichael E. Talkowski, James F. Gusella, Jill A. Rosenfeld et al.|Cell|2012Cited by 598
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease OnsetJong‐Min Lee, Richard H. Myers, Kevin Correia et al.|Cell|2019Cited by 558
A cross-disorder dosage sensitivity map of the human genomeRyan L. Collins, Håkon Håkonarson, Joseph Glessner et al.|Cell|2022Cited by 365
Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathiesMarta Marquié, Teresa Gómez‐Isla, Marc D. Normandin et al.|Annals of Neurology|2016Cited by 194